Category Archives: Healthcare

Healthcare Press Releases & News distributed via EuropaWire

Empa’s 4D X-Ray Breakthrough Reveals Shoulder Instabilities with Sub-Millimeter Precision

(IN BRIEF) Empa has introduced a novel 4D X-ray diagnostic that combines synchronized biplanar X-ray videos with CT-derived 3D bone models to quantify shoulder joint motion with 0.1–0.5 mm precision. This approach uncovers instabilities invisible to static imaging or skin-marker … Read the full press release

EIB Provides €150 Million to Fuel Alfasigma’s 2025–2027 R&D in Specialty and Rare-Disease Medicines

(IN BRIEF) The EIB has extended a €150 million loan to Alfasigma to fund its R&D efforts from 2025 to 2027, targeting new drugs in gastroenterology, hepatology, vascular medicine, rheumatology, and rare diseases. The financing, endorsed by EIB Vice-President Gelsomina … Read the full press release

University of Bristol Leads Development of First Global Information Guide for Innovative Surgery

(IN BRIEF) University of Bristol researchers and partners have created the first international Core Information Set (CIS) for innovative surgical procedures, published in the British Journal of Surgery. Arising from the 2018 “First Do No Harm” review, the CIS comprises … Read the full press release

BARDA Invests Additional USD 39 Million to Accelerate Phase 3 Trials of Basilea’s Fosmanogepix and BAL2062

(IN BRIEF) Basilea Pharmaceutica has secured an extra USD 39 million from BARDA under its Other Transaction Agreement, bringing potential non-dilutive funding to USD 268 million over 12 years. This new tranche will finance the ongoing phase 3 trial of … Read the full press release

Boehringer Ingelheim Launches Phase II Trial of Oral BI 1815368 to Treat Diabetic Macular Edema

(IN BRIEF) Boehringer Ingelheim has initiated the THULITE Phase II trial (NCT06962839) to assess BI 1815368, a novel oral agent for diabetic macular edema (DME). Affecting more than 21 million people globally, DME is typically managed by frequent eye injections, … Read the full press release

Aortic Aneurysms: EU-funded Pandora Project Brings In-Silico Modelling to Aid Surgeons

A European collaboration developing predictive tools to personalise aortic surgery, enhance prosthesis selection, and support clinical decision-making (IN BRIEF) PANDORA is an EU-funded collaboration uniting LivGemini, RBF Morph, INSA and UnivREN—alongside Rennes University Hospital—to create patient-specific “digital twins” of the … Read the full press release

EQT Healthcare Growth to Accelerate Europa Biosite’s Expansion in Europe and North America

(IN BRIEF) EQT Healthcare Growth will acquire a controlling interest in Europa Biosite from Adelis Equity. Europa Biosite, based in Stockholm, distributes over ten million life science research products—antibodies, biochemicals, diagnostic kits, and biospecimens—to more than 60,000 researchers across 17 … Read the full press release

Imfinzi Regimen Cuts Recurrence Risk by a Third and Boosts Two-Year Survival in Bladder Cancer

(IN BRIEF) The European Commission has approved AstraZeneca’s Imfinzi (durvalumab) combined with gemcitabine and cisplatin as neoadjuvant therapy, followed by Imfinzi adjuvant monotherapy, for adults with resectable muscle-invasive bladder cancer. This approval is anchored in NIAGARA Phase III trial data … Read the full press release

EIB Global and GIZ to Advise Kenyatta National Hospital on Solar PV Installation

(IN BRIEF) EIB Global, funded by a €50,000 Cities Climate Finance Gap Fund grant and in collaboration with GIZ, will advise Kenyatta National Hospital on installing a solar PV system. The technical studies and financial assessment will guide the integration … Read the full press release

University of Southampton and NHS Trust Launch £100 Million Institute for Medical Innovation

(IN BRIEF) The University of Southampton and University Hospital Southampton NHS Foundation Trust will open the £100 million Institute for Medical Innovation at Southampton General Hospital. This new building will co-locate researchers in medicine, engineering, and computer science to tackle … Read the full press release

BREAKING NEWS: New Podcast “Spreading the Good BUZZ” Hosted by Josh and Heidi Case Launches July 7th with Explosive Global Reach and a Mission to Transform Lives Through Hope and Community in Recovery

Sober.Buzz along with @SoberBuzzToken on Instagram are Impacting and Changing Lives Around the World with Real, Raw, Authentic Content is now a Member of the NXC Podcast Network Family which Further Expands Its Ability for “Spreading the Good BUZZ”  (IN … Read the full press release

Prudential and Prudence Foundation Launch Free Mental Health Support in Malaysia and Vietnam

(IN BRIEF) Prudential plc and its Prudence Foundation have partnered with Intellect to launch Talk It Out, a free mental health programme for underserved groups in Malaysia and Vietnam. Through the Intellect app—available in six local languages—users access self-help modules, … Read the full press release

Adyen and medicalforce Unite to Simplify In-Clinic Payments with One-Click Integration

(IN BRIEF) Adyen has been chosen by medicalforce Inc. to add in-person POS payments to its all-in-one clinic management SaaS. Previously limited to online credit-card transactions, medicalforce’s platform will now send invoice amounts directly to Adyen terminals via a single … Read the full press release

Scottish Universities Present Interactive Medical Ultrasound Innovations at Royal Society Summer Science Exhibition

(IN BRIEF) Between 1 and 6 July, the EPSRC Centre for Doctoral Training in Future Ultrasonic Engineering (FUSE CDT)—a collaboration led by the Universities of Glasgow and Strathclyde, with support from Dundee and King’s College London—will showcase its ultrasound research … Read the full press release

Roche Announces Retirement of pRED Head Hans Clevers and Communications Leader Barbara Schädler

(IN BRIEF) Roche has revealed that Dr. Hans Clevers, Head of Pharma Research and Early Development and board member since 2019, will retire from his pRED role at the end of August, though he will continue leading the Institute of … Read the full press release

European Society of Cardiology Endorses Vaccination as Key Tool to Prevent Heart Disease

(IN BRIEF) The European Society of Cardiology’s new Clinical Consensus Statement, published on 3 June 2025 in the European Heart Journal, positions vaccination as a core component of cardiovascular prevention. It reviews evidence that infections such as influenza, pneumonia, SARS-CoV-2, … Read the full press release

University of Dundee’s Professor Miratul Muqit Named First Director of UK DRI Parkinson’s Research Centre

(IN BRIEF) The University of Dundee has named Professor Miratul Muqit as inaugural Director of the UK Dementia Research Institute’s Parkinson’s Research Centre. Funded with £10 million, the centre aims to develop new predictive tools, preventive strategies, and treatments to … Read the full press release

FDA Grants Orphan Status to Sanofi’s Riliprubart for Preventing and Treating Transplant Rejection

(IN BRIEF) The FDA has awarded orphan drug designation to Sanofi’s riliprubart for the treatment of antibody-mediated rejection in solid organ transplants, highlighting the therapy’s potential in an area lacking approved options. Riliprubart, a humanized IgG4 antibody targeting activated C1s … Read the full press release

Expanding Horizons Secures £3.25 Million from NatWest to Acquire Enable Care Homes and Strengthen South Wales Services

(IN BRIEF) Expanding Horizons has acquired Enable Care Services (South Wales) Ltd, adding three care homes in Cwmbran and Argoed to its portfolio. This move, financed by a £3.25 million loan from NatWest, also funds refinancing and infrastructure upgrades to … Read the full press release

Roche Reports Zero Treatment-Requiring Bleeds with NXT007 in Phase I/II Haemophilia A Study

(IN BRIEF) Roche presented positive phase I/II data for NXT007, its Chugai-engineered bispecific antibody for haemophilia A, at the 2025 ISTH Congress. In the NXTAGE study’s highest-dose cohorts (B-3 and B-4), none of the 30 participants experienced bleeds requiring treatment, … Read the full press release